nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adherence to BCR-ABL Inhibitors: Issues for CML Therapy
|
Jabbour, Elias |
|
2012 |
12 |
4 |
p. 223-229 7 p. |
artikel |
2 |
Clinical Binding Properties, Internalization Kinetics, and Clinicopathologic Activity of Brentuximab Vedotin: An Antibody-Drug Conjugate for CD30-Positive Lymphoid Neoplasms
|
Fromm, Jonathan R. |
|
2012 |
12 |
4 |
p. 280-283 4 p. |
artikel |
3 |
Clinical Cytogenetics in Pediatric Acute Leukemia: An Update
|
Braoudaki, Maria |
|
2012 |
12 |
4 |
p. 230-237 8 p. |
artikel |
4 |
Cutaneous Lesion Induced by a Subcutaneous Administration of Bortezomib
|
Obeid, Karam M. |
|
2012 |
12 |
4 |
p. 284-286 3 p. |
artikel |
5 |
Detection of CD34, TdT, CD56, CD2, CD4, and CD14 by Flow Cytometry Is Associated With NPM1 and FLT3 Mutation Status in Cytogenetically Normal Acute Myeloid Leukemia
|
Dalal, Bakul I. |
|
2012 |
12 |
4 |
p. 274-279 6 p. |
artikel |
6 |
Does an Elevated Serum Vitamin B12 Level Mask Actual Vitamin B12 Deficiency in Myeloproliferative Disorders?
|
Gauchan, Dron |
|
2012 |
12 |
4 |
p. 269-273 5 p. |
artikel |
7 |
Editorial Board
|
|
|
2012 |
12 |
4 |
p. A6- 1 p. |
artikel |
8 |
Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients
|
Zinzani, Pier Luigi |
|
2012 |
12 |
4 |
p. 287-289 3 p. |
artikel |
9 |
Mutational Status and Gene Repertoire of IGHV-IGHD-IGHJ Rearrangements in Serbian Patients With Chronic Lymphocytic Leukemia
|
Karan-Djurasevic, Teodora |
|
2012 |
12 |
4 |
p. 252-260 9 p. |
artikel |
10 |
Pralatrexate Is an Effective Treatment for Relapsed or Refractory Transformed Mycosis Fungoides: A Subgroup Efficacy Analysis From the PROPEL Study
|
Foss, Francine |
|
2012 |
12 |
4 |
p. 238-243 6 p. |
artikel |
11 |
Table of Contents
|
|
|
2012 |
12 |
4 |
p. A7-A8 nvt p. |
artikel |
12 |
The Effects of Increased Expression of DLK1 Gene on the Pathogenesis of Myelodysplastic Syndromes
|
Ma, Xiaotang |
|
2012 |
12 |
4 |
p. 261-268 8 p. |
artikel |
13 |
Twice-Daily Fludarabine and Cytarabine Combination With or Without Gentuzumab Ozogamicin is Effective in Patients With Relapsed/Refractory Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, and Blast- Phase Chronic Myeloid Leukemia
|
Jabbour, Elias |
|
2012 |
12 |
4 |
p. 244-251 8 p. |
artikel |